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Abstract
Introduction: The largest known outbreak caused by a rare hybrid strain of Shiga toxin-producing E.coli (STEC) and
enteroaggregative E. coli (EAEC) (E.coli O104:H4) of serotype O104:H4 occurred in Germany in 2011. Fenugreek sprouts acted
as a transmission vehicle and were widely consumed in the outbreak area at the time of the epidemic. In total 3,842 people
developed a clinical illness caused by this strain; however the rates of asymptomatic infections remain unclear. We aimed to
develop a serological assay for detection of E.coli O104 LPS specific antibodies and to establish the post-outbreak levels of
seropositivity among people with documented exposure to contaminated sprouts.
Results and Discussion: Developed serological assays (ELISA with 84% sensitivity, 63% specificity and Western Blot with
100% sensitivity, 82.5% specificity) identified 33% (16/49) level of asymptomatic infection. Relatively small sample size and a
significant time- lapse between the onset of symptoms and serum samples collection (appr. 8 weeks) might explain the
assay variability. No association was found between clinical or demographic characteristics and assay positivity. Larger
studies are needed to understand the complexity of human immune response and factors influencing development of
clinical symptoms. Development of intra-outbreak research plans will substantially aid the conduct of more thorough
scientific investigation during an outbreak period.
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Introduction
From May to July 2011 the largest outbreak of severe illness
characterized by haemolytic-uraemic syndrome (HUS) and
bloody diarrhea affecting 3,842 people including 53 deaths
occurred in Germany, primarily in its northwestern part. The
outbreak was caused by a rare hybrid strain of Shiga toxin-producing
E.coli (STEC) and enteroaggregative E. coli (EAEC) of serotype O104:H4
(E.coli O104:H4) [1–3] with an extended spectrum of b-lactamase
resistance. The outbreak was associated with a number of non-
typical features such as older age of patients who were mainly
women, a higher proportion of patients developing HUS and a
high incidence of neurological symptoms. Fenugreek sprouts
were identified as the most likely transmission vehicle [4–6]. It
can be assumed that the sprouts were widely consumed in the
outbreak area at the time of the epidemic; however, only a
number of people developed clinical illness. It is unclear whether
some of the exposed individuals who remained healthy were also
infected.
An infection with toxin producing E.coli bacteria triggers the
production of serum antibodies directed against the lipopolysac-
charides (LPS) of the pathogen [7]. Therefore measurement of
antibodies against LPS by serological assays such as ELISA and
Western Blot (WB) has been widely used for diagnosis of a number
of illnesses caused by gram-negative organisms including E. coli
O157:H7 [7–9]. However, at the time of the outbreak an assay
able to give evidence of the antibody status after an infection with
the outbreak strain was not available.
We aimed to develop and validate a serological assay for
detection of E.coli O104 LPS-specific antibodies and to establish
the post-outbreak levels of seropositivity among a group of people
with documented exposure to the contaminated sprouts.
Methods
Ethics Statement
The study received an approval from the Charité University
Clinics Ethics Committee, Berlin. All study participants provided a
written informed consent to participate in the study.
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Assay development
Samples obtained from patients with culture-confirmed E.coli
O104:H4 infection (positive control group) and individuals
assumed not to be infected with this E.coli strain (negative control
group) were used for the assay validation. The culture-confirmed
patients were followed up by the Lübeck University clinic (n = 31;
21 were female and 28 presented with HUS). The median time
from the symptom onset to the blood sampling was 8 weeks
(range: 5 to 9 weeks). A group of negative controls (n = 473)
included residual samples obtained from blood donors residing in
a non-outbreak area (n = 444) and archived samples (n = 29) from
patients with culture-confirmed E.coli infections of serotypes other
than O104:H4 (O3, O26, O91, O103, O111, O145 and O157).
The latter specimens were collected within the framework of large
population-based surveys and were used for testing a possible
cross-reactivity. All samples were initially screened by the
developed specific ELISA assay; the results of all samples from
cases infected with non-outbreak strains and of a proportion of the
donors’ samples (all samples detected by ELISA as positive, weak
positive and a random number of negative samples) were
subsequently tested by a confirmatory WB assay able to visualize
the LPS diversity among the E.coli serotypes using O104 LPS as an
antigen [10]. ELISA was conducted according to the LPS-ELISA
method as published elsewhere [11]. The outbreak strain E.coli
O104:H4 was used for LPS preparation (Micromun, Greifswald,
Germany) and utilized at a concentration of 1 mg/ml for coating.
For the WB assay specific LPS profiles were prepared by SDS-
PAGE [12]. Purified O104 LPS (80 mg/gel) was loaded onto
preparative gels comprising 4% (w/v) acrylamide stacking gel and
12% (w/v) acrylamide separation gel. Electrophoresis was
conducted using the BioRad Mini Protean 3 (BioRad, Munich,
Germany) system with constant current of 40mA/gel. The
separated LPS was transferred onto a PVDF-membrane (Im-
mobilion, Millipore, Schwalbach, Germany) with 1 mA/cm2 for
1h. Subsequently the membrane was blocked with 10% milk
powder (in TBS-T) and cut into stripes, which were then
incubated with 1:500 or 1:1000 dilutions (in blocking buffer) of
the corresponding sera. Antigen-antibody complexes were detect-
ed using a goat anti-human polyvalent immunoglobulin, conju-
gated with horse-radish peroxidase (Dianova, Hamburg, Ger-
many), 0.2 mg/ml in blocking buffer, and TMB (Seramun,
Heidesee, Germany) as substrate. Antibody binding was assessed
by the intensity of the immunoblot reaction and the LPS profile.
Only serum samples that generated the specific O104 LPS profiles
were considered as positive for a recent O104:H4 infection linked
to the outbreak. In order to establish the dilution of sera that
provide the best specificity of the Western Blot assay several
negative control samples previously tested in ELISA as negative or
positive were titrated; the best discriminatory dilution was found at
1:1000 when all positive control sera also showed a positive result.
Study population
To evaluate the levels of seropositivity we invited individuals
with documented exposure to the contaminated sprouts to take
part in the study. These were the members of the three largest
visitor groups who had meals containing contaminated sprouts at a
particular restaurant (‘‘restaurant cohorts’’). Following the meal a
large number of them developed a gastroenteritic illness while the
rest stayed clinically healthy. Exposure to the sprouts was
documented for each individual through a careful examination
of the menus, interviews with the group members and a restaurant
chef as well as with an aid of available photos of the dishes made
by the restaurant visitors. Nearly half of the dishes served at the
restaurant during the period of the outbreak contained sprouts
that were purchased from one distributor [5]. This detailed
epidemiological investigation provided the key evidence support-
ing the fenugreek sprouts being a transmission vehicle and aided
implementation of adequate control measures.
A serum sample was taken from each participant for laboratory
examination after 6-9 months after the onset of the symptoms.
Results
Assay development and validation
Of 31 samples from the positive control group, 28 were
determined as positive and 3 as borderline by the ELISA resulting
in a sensitivity of 100% (when the borderline results are
interpreted as being positive). The ELISA identified 175 samples
from the negative control group as false positive thus demonstrat-
ing inadequate specificity of 63%.
The WB assay confirmed all 31 positive control samples as
positive (sensitivity 100%); however 17.6% (19/108) of the blood
donors’ specimens and 17.2% (5/29) of the specimens from
patients infected by non-outbreak strains were also falsely tested as
positive corresponding to an overall moderate specificity of 82.5%
(Table 1).
It is known that the O104 LPS of E.coli is structurally closely
related to the capsular K9 polysaccharide of E.coli [13], which is
only expressed with O groups 8 and 9 serotoypes of E.coli. To
check for this possible cross-reactivity several O104:H4 positive
serum samples were first tested against the following strains:
O9:K9:H12; O8:K9:H19; O9:K9:H19. All tested sera reacted
with the O9 strains (data not shown).
Culture-confirmed patients infected with E.coli of other than
O104:H4 serotypes were then tested in a two-step procedure. In
the first batch of samples of non-O157 serotypes (n = 9) the results
for all samples were negative. In the second batch of O157
serotypes (n = 20) only four reacted with the O104 LPS in the WB
assay and in one sample the reaction was borderline positive. In
summary no appreciable cross-reactions were observed with non-
O157 serotypes sera, whereas 25% results of the O157-serotype
group were false positive.
The rates of infection
Two-third of the invited persons (66/95; 69%) agreed to
participate in the study (67% female, median age 58 years,
interquartile age 47–70 years). All but two participants reported
sprout consumption. Comparable proportion of those who took
part in the study (17/66; 26%) and those who did not due to
difficulties related to the travel to the blood collection point (6/29;
21%) met the outbreak case definition [5]. Of the 14 culture
confirmed cases 8 (57%) were tested positive (Table 2): two persons
were severely ill with HUS and the remaining 6 had bloody
diarrhea without HUS. Two culture-negative patients were also
serologically positive. Of the 6 culture-confirmed patients who
were serologically negative, two had HUS and four had bloody
diarrhea only.
Of note, blood samples were taken from the restaurant cohorts’
members significantly later than from the patients used as positive
controls for the assay validation. The delay was related to the need
to finish outbreak investigations, to liaise with treating physicians
and potential study participants and to the time necessary for
obtaining an ethic approval for the study.
One third (33%) of the cohort members who were not clinically
ill were tested positive. Only two cohort members did not consume
sprouts and none of them was serologically positive. None of the
known clinical or demographic factors (gender, age, clinical
severity of illness) were associated with positivity on a univariate
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analysis; however the numbers were small to draw significant
conclusions. The rate of seropositivity detected by the WB among
the asymptomatic sprout-consumers (34.0%; 16/47) was signifi-
cantly higher (p = 0.018) than among the negative control group
(17.5%; 24/137).
Discussion and Conclusions
Within the framework of the study two consecutive serological
assays able to identify an infection with E.coli O104:H4 that had
caused the largest known outbreak in Germany in 2011 were
successfully developed. The development and validation proce-
dures were based on the known LPS antigenic status of gram
negative pathogens and the specific LPS structures of the outbreak
strain.
The validation data clearly showed the applicability of the
ELISA as a screening tool for testing a large number of samples; a
further testing by the WB assay is necessary to confirm the
diagnosis in ELISA-positive individuals although the results need
to be interpreted with caution and in conjunction with the
epidemiological data on exposure.
Fewer cohorts’ members who had been ill were identified as
serologicaly positive than the culture-confirmed patients from the
positive control group. Observed variability in the assay ability to
detect immunological responses might depend on the kinetics of
the antibodies formation, their decreasing stability and regression
against the O104 antigen due to the waning immunity phenom-
enon since a longer period of time elapsed between the onset of
symptoms and the sampling in the latter group (6–9 months
compared to the 6 weeks in the positive control group). Previously
reported data show that E. coli serotype O157 fails to induce a
lasting humoral immune response to the LPS O-antigen in
children with HUS leading to decrease in the ELISA signal 5–
6 weeks after onset on diarrhea and a level of IgM and IgG
antibody below the respective cutoff levels after 11 weeks [10].
Indeed the antibody titer of the positive patients in the study group
was lower than in the positive control group.
The study data suggest that a significant proportion of people
who remained clinically healthy were infected with E.coliO104:H4
after being exposed to contaminated sprouts during the outbreak
in Germany in 2011. Estimated likelihood ratio of a positive test
provides moderate evidence [14] that the positive assay results are
indeed associated with an infection by E. coli O104:H4. However,
even accounting for imperfect specificity and a 17.5% chance of a
false-positive result, at least 28% positivity rate among exposed but
not ill cohort members can be truly expected. Possible relation
between the exposure level and the intensity of clinical symptoms
might explain why a number of people remained healthy despite
consumption of the contaminated sprouts. Although the WB assay
has an excellent sensitivity we cannot rule out that not all infected
but clinically asymptomatic individuals were detected since some
of them might have had a low antibody response below the
detection limit.
It is known that people can be symptomless carriers of a
pathogen. The detection of serum antibodies to the LPS of O157
in apparently healthy individuals with occupational contact with
cattle suggested that exposure to low levels of the pathogen may
stimulate an immune response to the organism [7].
High positivity rate among negative controls could possibly be
explained by the prevalence of unrecognized infections caused by
other low pathogenic E.coli strains, as it is known, for example that
the O104 LPS and the capsular K9 polysaccharide found in E.coli-
Table 1. Performance characteristics of Western Blot in detecting E.coli O104:H4 antibodies.
Test characteristics n/N (%) 95%CI
Sensitivity 31/31 (100) 88.8–100
Specificity overall 113/137 (82.5) 75.1–88.4
Specificity: blood donors only 89/108 (82.4) –
Specificity: patients infected with non-O104:H4 STEC serotypes only 24/29 (82.8) –
LR+ 5.7 4.0–8.2
LR2 0 –
LR+ – likelihood ratio of a positive test; LR- -likelihood ratio of a negative test.
E. coli- Escherichia coli.
doi:10.1371/journal.pone.0073052.t001
Table 2. Positivity rates identified by the Western Blot (WB) assay among restaurant cohorts’ participants (n = 66).
Category of participants WB+ WB2 Positivity rate%
Cases* 10 7 59
Culture confirmed case 8 6 57
No culture confirmation 2 1 67
Non-case 16 33 33
Sprout consumption 16 31 34
No sprout consumption 0 2 0
All cohorts’ members 26 40 39
*All patients meeting the outbreak case definition including culture-negative cases (a case was defined as a patient with clinically diagnosed hemolytic-uremic
syndrome, bloody diarrhea and/or culture confirmation).
doi:10.1371/journal.pone.0073052.t002
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serotypes O8 and O9 share structural identities [13]. Both strains
are linked to urinary tract infections and septicemia [15]. Indeed
we have identified significant interactions of O104 samples with
the O9 serotype of E.coli; however the nature of the cross-reactivity
should be investigated further. In addition, developed assays detect
all infections caused by the O104 serogroup like e.g. O104:H21
which is known as the pathogen responsible for a small outbreak in
Helena, Montana in 1994 [16]. Little is known about the natural
appearance and infection incidence of the E.coli O104 serogroup
in Germany but it can be assumed that this serogroup has low
distribution.
For the O157 LPS of E.coli it has been shown that it shares
epitopes with the LPS from other bacterial pathogens, as e.g.
Yersinia enterocolitica or Brucella spp. [7]. Although current surveil-
lance data demonstrating low rates of infection with these
pathogens [17] making this explanation unlikely, it may be true
that O104:H4 cross-reacts with other gram- negative pathogens
thus resulting in imperfect specificity of the assay. Cross-reaction of
the tested O157 samples with the O104 LPS in a quarter of the
cases indicates that some epitopes remain similar between the
O157 and O104 O side chains.
The study was limited to the convenience sample of culture-
positive patients used for the validation purposes and to a relatively
small number of ill and healthy but exposed persons from the
restaurant cohorts thus permitting spectrum bias. We did not find
evidence to show that any of the clinical or demographic
characteristics were associated with being positive on the assay.
Accounting for imperfect test parameters, the test can be
probably recommended to be used in people with suspected severe
E.coli infection and HUS, especially in the absence of positive
culture confirmation but it is of a less value in identifying contacts
of infected people who are not severely ill.
Larger studies are needed to understand the complexity of
human immune response, risk factors for an initial infection as well
as factors influencing development of a clinical illness and the
severity of the symptoms. However small, this study might guide
the further research geared towards a better understanding of
susceptibility to the EHEC infections and the development of
rapid and accurate diagnostic tools.
One important conclusion relates to logistical difficulties in
conducting post-outbreak research. Hence development of ‘‘intra-
outbreak’’ research plans describing standard methodological
approaches to samples collection, data protection, ethical issues
and mechanisms for rapid pre-approval of studies, setting-up
common databases and information exchange mechanisms is
prompting. This plan could enable better quality research
resulting into evidence-based findings. In the time of a large
outbreak when all clinical, laboratory and epidemiological
resources are mobilized a clear algorithm of research-related
actions is needed.
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